BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 9401541)

  • 41. Endocrine phenotype of 6q16.1-q21 deletion involving SIM1 and Prader-Willi syndrome-like features.
    Izumi K; Housam R; Kapadia C; Stallings VA; Medne L; Shaikh TH; Kublaoui BM; Zackai EH; Grimberg A
    Am J Med Genet A; 2013 Dec; 161A(12):3137-43. PubMed ID: 24038875
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Thyroid function in patients with Prader-Willi syndrome: an Italian multicenter study of 339 patients.
    Iughetti L; Vivi G; Balsamo A; Corrias A; Crinò A; Delvecchio M; Gargantini L; Greggio NA; Grugni G; Hladnik U; Pilotta A; Ragusa L; Salvatoni A; Wasniewska M; Weber G; Predieri B
    J Pediatr Endocrinol Metab; 2019 Feb; 32(2):159-165. PubMed ID: 30703060
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Body composition, endocrine and metabolic profiles in adults with Prader-Willi syndrome.
    Sode-Carlsen R; Farholt S; Rabben KF; Bollerslev J; Schreiner T; Jurik AG; Christiansen JS; Höybye C
    Growth Horm IGF Res; 2010 Jun; 20(3):179-84. PubMed ID: 20199883
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Prader-Willi syndrome].
    Heiberg A; Lofterød B
    Nord Med; 1991; 106(6-7):189-90. PubMed ID: 1852594
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Endocrine disorders in children with Prader-Willi syndrome--data from 142 children of the French database.
    Diene G; Mimoun E; Feigerlova E; Caula S; Molinas C; Grandjean H; Tauber M;
    Horm Res Paediatr; 2010; 74(2):121-8. PubMed ID: 20395666
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical effects of treatment for hypogonadism in male adolescents with Prader-Labhart-Willi syndrome.
    Eiholzer U; Grieser J; Schlumpf M; l'Allemand D
    Horm Res; 2007; 68(4):178-84. PubMed ID: 17374959
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Thyroid axis dysfunction in patients with Prader-Willi syndrome during the first 2 years of life.
    Vaiani E; Herzovich V; Chaler E; Chertkoff L; Rivarola MA; Torrado M; Belgorosky A
    Clin Endocrinol (Oxf); 2010 Oct; 73(4):546-50. PubMed ID: 20560980
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pubertal development in the Prader-Labhart-Willi syndrome.
    Kauli R; Prager-Lewin R; Laron Z
    Acta Paediatr Scand; 1978 Nov; 67(6):763-7. PubMed ID: 362802
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Testicular failure in boys with Prader-Willi syndrome: longitudinal studies of reproductive hormones.
    Siemensma EP; de Lind van Wijngaarden RF; Otten BJ; de Jong FH; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2012 Mar; 97(3):E452-9. PubMed ID: 22188746
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Normal minipuberty of infancy in boys with Prader-Willi syndrome.
    Fillion M; Deal CL; Van Vliet G
    J Pediatr; 2006 Dec; 149(6):874-6. PubMed ID: 17137911
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transition in endocrinology: induction of puberty.
    Dunkel L; Quinton R
    Eur J Endocrinol; 2014 Jun; 170(6):R229-39. PubMed ID: 24836550
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Auxological and endocrine evolution of 28 children with Prader-Willi syndrome: effect of GH therapy in 14 children.
    Tauber M; Barbeau C; Jouret B; Pienkowski C; Malzac P; Moncla A; Rochiccioli P
    Horm Res; 2000; 53(6):279-87. PubMed ID: 11146368
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Primary ovarian dysfunction contributes to the hypogonadism in women with Prader-Willi Syndrome.
    Eldar-Geva T; Hirsch HJ; Rabinowitz R; Benarroch F; Rubinstein O; Gross-Tsur V
    Horm Res; 2009; 72(3):153-9. PubMed ID: 19729946
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The GH/IGF-I axis and pituitary function and size in adults with Prader-Willi syndrome.
    van Nieuwpoort IC; Sinnema M; Castelijns JA; Twisk JW; Curfs LM; Drent ML
    Horm Res Paediatr; 2011; 75(6):403-11. PubMed ID: 21273761
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Endocrine function and morphological findings in patients with disorders of the hypothalamo-pituitary area: a study with magnetic resonance.
    Cacciari E; Zucchini S; Carlà G; Pirazzoli P; Cicognani A; Mandini M; Busacca M; Trevisan C
    Arch Dis Child; 1990 Nov; 65(11):1199-202. PubMed ID: 2248527
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Noonan syndrome: the hypothalamo-adrenal and hypothalamo-gonadal axes.
    Kelnar CJ
    Horm Res; 2009 Dec; 72 Suppl 2():24-30. PubMed ID: 20029233
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Behaviorally induced reproductive compromise in women and men.
    Berga SL
    Semin Reprod Endocrinol; 1997 Feb; 15(1):47-53. PubMed ID: 9065977
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Activity levels of persons with Prader-Willi syndrome.
    Nardella MT; Sulzbacher SI; Worthington-Roberts BS
    Am J Ment Defic; 1983 Mar; 87(5):498-505. PubMed ID: 6837640
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Short-term Assessment of HSCT Effects on the Hypothalamus-Pituitary Axis in Pediatric Thalassemic Patients.
    Hamidieh AA; Mohseni F; Behfar M; Hamidi Z; Alimoghaddam K; Pajouhi M; Larijani B; Mohajeri-Tehrani MR; Ghavamzadeh A
    Arch Iran Med; 2018 Feb; 21(2):56-60. PubMed ID: 29664655
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ovarian function and reproductive hormone levels in girls with Prader-Willi syndrome: a longitudinal study.
    Siemensma EP; van Alfen-van der Velden AA; Otten BJ; Laven JS; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2012 Sep; 97(9):E1766-73. PubMed ID: 22723315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.